Rare Disease Formulations

Preventor designs, develops, analyzes and validates together with its cooperation partners/regulatory authorities novel and innovative preferably sustainable, plant based formulations using cutting edge technology applied to unmet medical needs encompassing both pre-clinical and clinical phase 1a (First-in-Human)

and 1b/2a (Proof-of-Concept) clinical trials targeted at rare diseases requiring affordable, sustainable symptomatic or curative treatment alternatives with no or very marginal side effects delivering value and improving quality of life to patients worldwide.